Clinically depressed patients reportedly have impaired glutamatergic and hyperactive acetylcholine systems, whereas they have a dramatically suppressed gamma-aminobutyric acid (GABA) system (Pytka et al., 2016
Investment Strategy, Section 5 CDMOs with established flow chemistry and continuous manufacturing capabilities are structurally advantaged in the current drug development environment
Until recently, however, evidence for why people quit has been anecdotal
Boxed Warning (Thyroid C-Cell Tumor Risk) GLP-1 receptor agonists, including semaglutide, carry an FDA boxed warning regarding the potential risk of thyroid C-cell tumors
Recently, a class of medications called GLP-1 inhibitors, primarily known for their role in weight management and diabetes, has sparked interest in the mental health community